Saturday 17 October 2026
Export CABR’s income statement to Excel — free account
Caring Brands, Inc.
CABR Healthcare Drug Manufacturers Specialty & Generic
Caring Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4,200.00, up 740.0% from fiscal 2024. In the quarter to June 2026, EPS fell 102.0% and free cash flow fell 121.3%, each against the same quarter a year earlier.
1.22
0.07
−5.43%
Follow CABR
| Dec '24 | Dec '25 | |
|---|---|---|
P/E ratio |
0.00 | 0.00 |
Altman Z-Score |
— | 18.05 |
P/S ratio |
0.00 | 2,777.62 |
P/FCF ratio |
0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
18.03 | (11.76) |
P/Operating CF |
(61.69) | (11.00) |
P/B ratio |
4.29 | 5.58 |
Price to Tangible BV |
0.00 | 0.00 |
EV/Sales |
0.00 | 2,270.35 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
(12.32) | (5.63) |
EV/FCF |
(12.32) | (5.63) |
Quick Ratio |
2.52 | 12.38 |
Current Ratio |
2.83 | 13.16 |
Net Debt/EBITDA |
0.34 | 0.38 |
Debt/Assets |
0.00% | 2.52% |
Debt/Equity |
0.00 | 0.03 |
Asset Turnover |
0.00 | 0.00 |
Operating CF/Net income |
0.54 | 0.27 |
Capex/Depreciation |
0.00 | 0.00 |
Interest Coverage |
152.74 | (309.11) |
| 0.00% | (217.14%) | |
| 0.00% | (202.38%) | |
ROIC |
(29.62%) | 0.00% |
Return on Tangible Assets |
(444.46%) | (292.01%) |
Average Days of Receivables |
0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
20,660.00% | 3,516.67% |
Intangible Assets out of Total Assets |
0.74 | 0.00 |
Share Based Compensation of Revenue |
80,000.00% | 29,492.86% |
Graham Net Nets |
(0.05) | 0.18 |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
(26.04%) | (53.52%) |
Free Cash Flow Yield |
(8.11%) | (14.51%) |
Revenue per Share |
0.00 | 0.00 |
Operating CF per Share |
(0.06) | (0.12) |
Capex per Share |
0.00 | 0.00 |
Free Cash Flow per Share |
(0.06) | (0.12) |
Cash per Share |
0.04 | 0.16 |
Shareholders Equity per Share |
0.28 | 0.15 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
0.28 | 0.15 |
Free Cash Flow |
(0.82) | (1.69) |
Working Capital |
0.34 | 2.15 |
Net Current Asset Value |
0.34 | 2.09 |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
0.00 | 0.00 |
Cash ROIC |
(19.81%) | (39.00%) |
Accounts Receivable Turnover |
0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.01 |
Inventory Turnover |
0.00 | 0.14 |
Average Days of Payables |
29,443.33 | 32,734.74 |
Days of Inventory on Hand |
2,381.19 | 2,458.95 |
Average Payables |
— | 0.17 |
Average Inventory |
— | 0.01 |
Average Assets |
— | 3.10 |
Average Common Equity |
— | 2.89 |
Columns are period end dates